Organ-specific manifestations of COVID-19 infectionMaria Gavriatopoulou, Meletios Α. Dimopoulos|Clinical and Experimental Medicine|2020Cited by 518
Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health WorkersEvangelos Terpos, Meletios Α. Dimopoulos, Ioannis P. Trougakos et al.|Cells|2021Cited by 46
Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA TherapyIoannis Ntanasis‐Stathopoulos, Evangelos Terpos, Vangelis Karalis et al.|HemaSphere|2022Cited by 44
High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic EventsEvangelos Terpos, Meletios Α. Dimopoulos, Marianna Politou et al.|Vaccines|2021Cited by 30
Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222Evangelos Terpos, Meletios Α. Dimopoulos, Vangelis Karalis et al.|Biomedicines|2022Cited by 29